Pemphigus foliaceous in a dog - clinical and laboratorial assessment

Background: The pemphigus complex is defined as a group of blistering autoimmune diseases that affects skin and mucous membrane. Pemphigus foliaceous is the most common disease in this group, being characterized by the productionof autoantibodies against keratinocyte adhesion molecules. The treatment is based on the use of immunosuppressive drugsand requires constant monitoring to assess inflammatory control as well as side effects of therapy. Based on that, the aimof this study was to report the clinical and laboratorial follow-up of a canine with pemphigus foliaceous.Case: An 11-year-old male neutered mongrel dog, weighing 9.8 kg, was presented with a main complaint related to disseminated pruritus and lesions in face, trunk and limbs. Dermatological examination revealed meliceric crusts, epidermalcollars and diffuse pustules in inguinal, abdominal, face, limbs, ears and thoraco-lumbar regions. Cytological examinationwas performed, revealing inflammatory and acantholytic cells and absence of bacterial cells. Biopsy procedure revealedsubcorneal pustule with presence of epithelial acantholytic cells and neutrophils, compatible with canine pemphigusfoliaceous. Hemato-biochemical analysis revealed a leukocytosis due to increased neutrophil count. Systemic treatmentwith high dose of prednisolone (2.0 mg/kg) and azathioprine (2.5 mg/kg) was proposed, while topical therapy with a 3%chlorhexidine shampoo was used to prevent secondary bacterial infections. The patient improved the dermatological clinicalsigns, being possible to observe a reduction of systemic and tissue inflammatory process. After 90 days of therapy, therewas a partial loss of hair body coverage, associated with follicular lesions, and after 180 days of therapy it was possibleto notice a new hair mantle, without visible areas of inflammation...

Pemphigus foliaceous in a dog - clinical and laboratorial assessment

Background: The pemphigus complex is defined as a group of blistering autoimmune diseases that affects skin and mucous membrane. Pemphigus foliaceous is the most common disease in this group, being characterized by the productionof autoantibodies against keratinocyte adhesion molecules. The treatment is based on the use of immunosuppressive drugsand requires constant monitoring to assess inflammatory control as well as side effects of therapy. Based on that, the aimof this study was to report the clinical and laboratorial follow-up of a canine with pemphigus foliaceous.Case: An 11-year-old male neutered mongrel dog, weighing 9.8 kg, was presented with a main complaint related to disseminated pruritus and lesions in face, trunk and limbs. Dermatological examination revealed meliceric crusts, epidermalcollars and diffuse pustules in inguinal, abdominal, face, limbs, ears and thoraco-lumbar regions. Cytological examinationwas performed, revealing inflammatory and acantholytic cells and absence of bacterial cells. Biopsy procedure revealedsubcorneal pustule with presence of epithelial acantholytic cells and neutrophils, compatible with canine pemphigusfoliaceous. Hemato-biochemical analysis revealed a leukocytosis due to increased neutrophil count. Systemic treatmentwith high dose of prednisolone (2.0 mg/kg) and azathioprine (2.5 mg/kg) was proposed, while topical therapy with a 3%chlorhexidine shampoo was used to prevent secondary bacterial infections. The patient improved the dermatological clinicalsigns, being possible to observe a reduction of systemic and tissue inflammatory process. After 90 days of therapy, therewas a partial loss of hair body coverage, associated with follicular lesions, and after 180 days of therapy it was possibleto notice a new hair mantle, without visible areas of inflammation...(AU)

Mupirocin pemphigus-like drug reaction in a dog

Background: Pharmacodermia is defined as adverse reaction in skin, mucosa and appendages, which generates morphofunctional alterations in cutaneous barrier, inducing autoimmune diseases, such as pemphigus foliaceous, which is known asthe most common autoimmune skin disease in dogs. This disease involves autoantibodies against desmoglein and desmocolinmolecules, being induced by the use of certain drugs. Mupirocin (pseudomonic acid A) is a broad-spectrum antibiotic withbacteriostatic activity, being effective against Gram-positive pathogens and used to control superficial bacterial folliculitis.Based on that, the aim of this study was to report a pemphigus-like lesions after topical use of mupirocin in dog.Case: An 1-year-old, uncastrated male, Poodle dog, weighing 13.8 kg was treated in a private clinic in Fortaleza. The maincomplaint was related to pruritus in abdominal and inguinal region, in addition of legs licking. Dermatological examination revealed melanic crusts, epidermal collars and diffuse pustules in inguinal, abdominal, perianal and thoraco-lumbarregions. The therapy was based on topical use of Mupirocin in form of 0.2% aquous spray. After drug administration, theanimal presented urticaria, diffuse epidermal collars, papulo-crusted and pustular lesions, which were more evident inabdominal and inguinal region. Nasal erythema, binocular blepharitis, apathy and fever were also observed. Cytologicalexamination and bacterial culture were performed, revealing inflammatory and acantholytic cells and no bacterial growth.Biopsy procedure revealed subcorneal pustule with presence of epithelial acantholytic cells and neutrophils, compatiblewith canine pemphigus foliaceous. The topical treatment of ocular lesions with 0.1% Tacrolimus associated with systemictreatment with high dose of prednisolone (1.2 mg kg-1)...

Mupirocin pemphigus-like drug reaction in a dog

Background: Pharmacodermia is defined as adverse reaction in skin, mucosa and appendages, which generates morphofunctional alterations in cutaneous barrier, inducing autoimmune diseases, such as pemphigus foliaceous, which is known asthe most common autoimmune skin disease in dogs. This disease involves autoantibodies against desmoglein and desmocolinmolecules, being induced by the use of certain drugs. Mupirocin (pseudomonic acid A) is a broad-spectrum antibiotic withbacteriostatic activity, being effective against Gram-positive pathogens and used to control superficial bacterial folliculitis.Based on that, the aim of this study was to report a pemphigus-like lesions after topical use of mupirocin in dog.Case: An 1-year-old, uncastrated male, Poodle dog, weighing 13.8 kg was treated in a private clinic in Fortaleza. The maincomplaint was related to pruritus in abdominal and inguinal region, in addition of legs licking. Dermatological examination revealed melanic crusts, epidermal collars and diffuse pustules in inguinal, abdominal, perianal and thoraco-lumbarregions. The therapy was based on topical use of Mupirocin in form of 0.2% aquous spray. After drug administration, theanimal presented urticaria, diffuse epidermal collars, papulo-crusted and pustular lesions, which were more evident inabdominal and inguinal region. Nasal erythema, binocular blepharitis, apathy and fever were also observed. Cytologicalexamination and bacterial culture were performed, revealing inflammatory and acantholytic cells and no bacterial growth.Biopsy procedure revealed subcorneal pustule with presence of epithelial acantholytic cells and neutrophils, compatiblewith canine pemphigus foliaceous. The topical treatment of ocular lesions with 0.1% Tacrolimus associated with systemictreatment with high dose of prednisolone (1.2 mg kg-1)...(AU)